Background/Objectives Oxidative stress and chronic in ammation are both major underlying factors for the initiation and progression of diabetes as well as for the development of long-term diabetes-related consequences in patients with type 2 diabetes mellitus (T2DM). This study was designed to evaluate the effects of concentrated beetroot juice (BJ) consumption on oxidative stress and in ammatory markers in patients with T2DM.Methods In this 12-weeks randomized clinical trial, forty-six patients with T2DM were randomly assigned to either the concentrated BJ or the control group. The BJ group received 12 ml concentrated beetroot juice twice daily, whereas the control group received no intervention. At baseline and the end of week 12, plasma levels of malondialdehyde (MDA), high sensitive C-reactive protein (hs-CRP), interleukin-6 (IL-6), and tumor necrosis factor-α (TNF-α), and nuclear factor-κB (NF-κB) were measured.Results Compared with control group, concentrated BJ reduced IL-6 (−0.1 vs. 0.83, p = .001), TNF-α (−1.28 vs. 5.51, p = .001), and NF-κB (−0.03 vs. 0.36, p = .005) after 12 weeks intervention; plasma concentration of MDA and hs-CRP did not change between groups after intervention. Intra-group comparison with paired t-test disclosed that daily BJ consumption could not change oxidative stress and in ammatory markers except for TNF-α compared with baseline values. However, the concentrations of IL-6, TNF-α, and NF-κB increased signi cantly in the control group at the end of week 12 compared to baseline (p = .001, p = .001, p = .021, respectively).Conclusions In conclusion, our study indicates that daily consumption of 24 ml concentrated BJ to patients with T2DM reduces the concentrations of some in ammatory markers including IL-6, TNF-α, and NF-κB which are involved in the pathogenesis of complications of T2DM.Trial Registration This study was registered at the Iranian Registry of Clinical Trials (IRCT) with the following identi cation: IRCT20150815023617N5.